About Justin DiMartino
Form D filings for Mach5 Therapeutics in 2024 list Justin DiMartino as executive officer and director.
Justin DiMartino first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Justin DiMartino in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Justin DiMartino works with at each company, as listed on that company's latest Form D.
Mach5 Therapeutics, Inc. · Form D, Nov 4, 2024
PC
Patrick Crutcher
Chief Executive Officer and director